Interferon-gamma immunotherapy in a patient with refractory disseminated candidiasis

Pediatric Infectious Disease Journal

Volumn 34, Issue 12, 2015, Pages 1391-1394

  Buddingh, Emilie P ^a   Leentjens, Jenneke ^b   Van Der Lugt, Jasper ^c   Dik, Willem A ^c   Gresnigt, Mark S ^b   Netea, Mihai G ^b   Pickkers, Peter ^b   Driessen, Gertjan J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Candida; immunotherapy; interferon gamma; leukemia

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; FLUCYTOSINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; MICAFUNGIN; VANCOMYCIN; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ARTICLE; ASSISTED VENTILATION; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANDIDA DUBLINIENSIS; CANDIDIASIS; CASE REPORT; CENTRAL NERVOUS SYSTEM; CENTRAL VENOUS CATHETER; CHILD; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; HUMAN; IMMUNE RESPONSE; INDUCTION CHEMOTHERAPY; INVASIVE CANDIDIASIS; MALE; NEUROIMAGING; NEUTROPENIA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGIST; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY BURST; SALVAGE THERAPY; BRAIN; LEUKEMIA; PATHOLOGY;

BRAIN; CANDIDIASIS; CHILD, PRESCHOOL; HUMANS; INDUCTION CHEMOTHERAPY; INTERFERON-GAMMA; LEUKEMIA; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84944339177     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000909     Document Type: Article

References (19)

1. Wiley JM, Smith N, Leventhal BG, Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J Clin Oncol 1990 8 280 286
2. Schwartz RS, Mackintosh FR, Schrier SL, Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984 53 411 419
3. Richet HM, Andremont A, Tancrede C, Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991 13 211 215
4. Martino P, Girmenia C, Micozzi A, Fungemia in patients with leukemia. Am J Med Sci 1993 306 225 232
5. Viscoli C, Girmenia C, Marinus A, Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999 28 1071 1079
6. Chalmers C, Gaur S, Chew J, Epidemiology and management of candidaemia-A retrospective, multicentre study in five hospitals in the UK. Mycoses 2011 54 e795 e800
7. Vogiatzi L, Ilia S, Sideri G, Invasive candidiasis in pediatric intensive care in Greece: a nationwide study. Intensive Care Med 2013 39 2188 2195
8. Steinbach WJ, Roilides E, Berman D, International Pediatric Fungal Network Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J 2012 31 1252 1257
9. Fraser VJ, Jones M, Dunkel J, Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992 15 414 421
10. Poynton CH, Barnes RA, Rees J, Interferon gamma and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clin Infect Dis 1998 26 239 240
11. Dignani MC, Rex JH, Chan KW, Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer 2005 104 199 204
12. Leentjens J, Kox M, van der Hoeven JG, Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 2013 187 1287 1293
13. Delsing CE, Gresnigt MS, Leentjens J, Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis 2014 14 166
14. Leentjens J, Kox M, Koch RM, Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 2012 186 838 845
15. Vonk AG, Netea MG, van der Meer JW, Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Expert Opin Biol Ther 2006 6 891 903
16. Netea MG, Maródi L, Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 2010 31 346 353
17. Huang W, Na L, Fidel PL, Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004 190 624 631
18. Tissières P, Ochoda A, Dunn-Siegrist I, Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PLoS One 2012 7 e32863
19. Marciano BE, Wesley R, De Carlo ES, Long-Term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004 39 692 699